APRIL VINOPAL: Open Payments
NPI 1770536021 · BEAVER FALLS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,632 in 122 payments from 18 companies in 2025. Trend: 2023 $934 · 2024 $1,868 · 2025 $2,632
Food & beverage: $2,632
| Company | Payments | Amount |
|---|---|---|
| Madrigal Pharmaceuticals | 14 | $529 |
| ABBVIE INC. | 25 | $462 |
| Ardelyx, Inc. | 11 | $265 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $239 |
| PFIZER INC. | 13 | $233 |
| Janssen Biotech, Inc. | 9 | $184 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 10 | $159 |
| Phathom Pharmaceuticals, Inc. | 7 | $131 |
| GENZYME CORPORATION | 5 | $108 |
| VIVUS LLC | 4 | $68 |
Products named: REZDIFFRA, IBSRELA, TREMFYA, SKYRIZI, XELJANZ, ENTYVIO, DUPIXENT, RINVOQ.
Industry payments across PA — which companies pay providers there.
